Following studies by another group showed that PTEN-deficient GBM patients, which have down-regulated HR, can benefit from the combination of PARP inhibitors with the standard treatment of GBM, which is the combination of ionizing radiation and temozolomide.152. This evidence concerns the gene PARP1 and glioblastoma.